Previous studies have shown that single nucleotide polymorphisms (SNPs) in the hsa-miR-548 family binding site at the glyceraldehyde-3-phosphate dehydrogenase alter susceptibility to breast cancer [27]. The gene discussed is GAPDH; the disease is breast carcinoma.